作者: Margaret K. Kyle
DOI: 10.1162/REST.89.1.88
关键词:
摘要: Abstract This paper finds that the use of price controls has a statistically and quantitatively important effect on extent timing launch new drugs. Firms headquartered in countries regulate reach fewer markets than those without controls. Companies avoid price-controlled markets, are less likely to introduce products additional after entering country. Launches into low-price European further delayed following legalization parallel imports. The results suggest regulation one country affects entry other countries, may affect strategies domestic firms.